Travel-associated carbapenem-resistant organisms at a time of increasing geopolitical instability: a UK perspective
Travel-associated carbapenem-resistant organisms at a time of increasing geopolitical instability: a UK perspective
Background: conflict and catastrophe compromise multinational healthcare delivery and present risks for the spread of carbapenem-resistant organisms (CROs). UK risk and ability to detect travel-associated CROs remains unclear.
Methods: a 10-question survey was sent to microbiology/infection prevention & control (IPC) practitioners of 108 UK acute NHS Trusts/Regions/Boards, exploring recent experience and IPC practices for travel-associated CROs and approaches to extended-spectrum antimicrobial testing. Additionally, major trauma network centres were invited to review detected carbapenemase-producing organism (CPO) molecular data from March 2022-April 2024, comparing associated travel by WHO global region using one-way ANOVA.
Results: seventy-three surveys were returned. IPC approaches were highly variable, with 19/73 (26.0%) centres requiring modification to national screening guidelines. 24/73 (32.8%) centres reported CROs associated with recent travel to major conflict areas. Twelve major trauma network centres contributed to review of detected CPOs, finding 297/1290 (23.0%) individuals with travel to 52 different countries. 227/297 (76.4%) were screening results; 279/297 (93.9%) were Enterobacterales. 112/297 (37.7%) had travelled to Europe, where carbapenemase diversity was greater than elsewhere (p<0.001).
Interpretation: a considerable range of UK centres are detecting CROs associated with travel to areas of current major conflict. A more didactic approach to travel history on first contact with healthcare services is required to stratify CPO risk at admission. These data should be collected prospectively in parallel with projects which successfully embed taking an effective travel history to assess risk of travel-associated infectious disease. This will allow clearer understanding of travel behaviours and trends, delineate risk and inform effective IPC.
Antimicrobial resistance, Global health security, Infection prevention and control, Screening, Surveillance
143-150
Pallett, S.J.C.
eb80d6b3-9cc1-4efa-8f75-4b2a6f16abfc
Boyd, S.E.
de338bfd-55a0-4c3b-99eb-44702750cab7
Khanijau, A.
30ddd3bd-a0a2-4f2d-b799-a7e6528b2663
Banerjee, R.
06517d0f-9be4-49c4-a2ac-00cf495e2a52
Reec, N.
ff2bc970-32ad-497d-b7f7-60040dda215e
Jawad, S.
d15da0c8-7bab-46d8-bbd6-a9b6442a278c
Daniel, V.
a8a7d6fd-9fa8-4915-940c-4ed0a33de969
Routledge, M.
876186d4-ab3e-4edb-beb7-4caf0792af67
Navalan, H.
44fcc95b-96db-46fb-a65c-9a7fa2e91dc8
Saeed, K.
87cb67e5-71e8-4759-bf23-2ea00ebd8b39
Lambourne, J.
bbdf9dd7-d524-405f-a643-d0b01687c1ef
Enoch, D.A.
758483d3-a8b0-45a6-88b3-c11289bc7c75
Shanks, G.
4373ac85-2756-4ce2-998f-e4fcaa5b9a2a
Cai, J.
bfd556ce-a474-4dcf-aac1-6a654c483aa9
Wild, A.
2baa2768-71ba-419a-b289-706d98c001f0
Mahida, N.
512ab4af-1f99-4194-aeb1-cb1302fdb680
Hiles, H.
a7d52ab5-6bf6-4bf3-b111-d3c65c8623c2
Parsons, H.
694189a1-8e0f-493a-b973-a38caad49365
Tickell-Painter, M.
48122845-b649-4aea-98e6-6ed44f8c1335
Shorten, R.
ef5cd70a-ee7a-4db2-97c2-de528e4db0ba
Srirathan, V.
73958e25-2b8a-432d-9479-a34864650ed5
Suich, J.
1e13867f-e450-4194-ac36-8fe9ae25f6e2
Wearmouth, D.
47702f3d-419c-4270-acfa-4604a54e87e0
Dhillon, R.
4a526e3c-59e0-47c9-934d-4defd8b20f9f
Mughal, N.
d98787cf-d435-4fd1-bb14-cfa7baf4ebfb
Woolley, S.D.
b046534f-18f3-4942-ace6-61e17bc34450
O'Shea, M.K.
5371d186-3291-4b54-8dfd-ec3b71601311
Moore, L.S.P.
6645b537-50ac-4189-b270-55301bce3d64
27 January 2026
Pallett, S.J.C.
eb80d6b3-9cc1-4efa-8f75-4b2a6f16abfc
Boyd, S.E.
de338bfd-55a0-4c3b-99eb-44702750cab7
Khanijau, A.
30ddd3bd-a0a2-4f2d-b799-a7e6528b2663
Banerjee, R.
06517d0f-9be4-49c4-a2ac-00cf495e2a52
Reec, N.
ff2bc970-32ad-497d-b7f7-60040dda215e
Jawad, S.
d15da0c8-7bab-46d8-bbd6-a9b6442a278c
Daniel, V.
a8a7d6fd-9fa8-4915-940c-4ed0a33de969
Routledge, M.
876186d4-ab3e-4edb-beb7-4caf0792af67
Navalan, H.
44fcc95b-96db-46fb-a65c-9a7fa2e91dc8
Saeed, K.
87cb67e5-71e8-4759-bf23-2ea00ebd8b39
Lambourne, J.
bbdf9dd7-d524-405f-a643-d0b01687c1ef
Enoch, D.A.
758483d3-a8b0-45a6-88b3-c11289bc7c75
Shanks, G.
4373ac85-2756-4ce2-998f-e4fcaa5b9a2a
Cai, J.
bfd556ce-a474-4dcf-aac1-6a654c483aa9
Wild, A.
2baa2768-71ba-419a-b289-706d98c001f0
Mahida, N.
512ab4af-1f99-4194-aeb1-cb1302fdb680
Hiles, H.
a7d52ab5-6bf6-4bf3-b111-d3c65c8623c2
Parsons, H.
694189a1-8e0f-493a-b973-a38caad49365
Tickell-Painter, M.
48122845-b649-4aea-98e6-6ed44f8c1335
Shorten, R.
ef5cd70a-ee7a-4db2-97c2-de528e4db0ba
Srirathan, V.
73958e25-2b8a-432d-9479-a34864650ed5
Suich, J.
1e13867f-e450-4194-ac36-8fe9ae25f6e2
Wearmouth, D.
47702f3d-419c-4270-acfa-4604a54e87e0
Dhillon, R.
4a526e3c-59e0-47c9-934d-4defd8b20f9f
Mughal, N.
d98787cf-d435-4fd1-bb14-cfa7baf4ebfb
Woolley, S.D.
b046534f-18f3-4942-ace6-61e17bc34450
O'Shea, M.K.
5371d186-3291-4b54-8dfd-ec3b71601311
Moore, L.S.P.
6645b537-50ac-4189-b270-55301bce3d64